Ledger.Open graph →
SEC Form D · filed August 12, 2021

Praesidia Biotherapeutics, Inc

Offering
$10.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ARLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Sohang Chatterjee · Arlington, MAExec · DirectorPradip Majumder · Arlington, MAExecMartin Lehr · Philadelphia, PADirectorShawn Titcomb · Lauderdale by the Sea, FLDirectorDouglas J. Crozier · Amarillo, TXDirectorDal C. Reid · Amarillo, TXExec · DirectorMichael Blady · VANCOUVER, British Columbia, CanadaDirectorClayton M. Olson · VANCOUVER, British Columbia, CanadaExecKevin Logan · San Francisco, CADirectorCurtis A. Lockshin · Marlborough, MAExecRobert J. Bitterman · Marlborough, MADirectorRobert A. Ferrara · Marlborough, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗